Sanofi, Regeneron Expand Immunology Alliance in Up to $8B Deal

Sanofi and Regeneron have closed an expansion of their immunology co-development and marketing alliance, with a potential value of up to $8 billion for Regeneron. The deal deepens an existing partnership, signaling continued investment in immunology pipelines. Financial terms and specific programs remain undisclosed, limiting immediate market impact assessment.